查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1716851

臨床試驗設備和支援解決方案市場（按組件、階段、治療領域和最終用戶分類）—2025-2030 年全球預測

Clinical Trial Equipment & Ancillary Solutions Market by Component, Phase, Therapeutic Area, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024年臨床試驗設備和輔助解決方案市值為45.8億美元，預計2025年將成長至50億美元，複合年成長率為8.84%，預計到2030年將達到76.2億美元。

主要市場統計數據
基準年2024年 45.8億美元
預計2025年 50億美元
預測年份 2030 76.2億美元
複合年成長率（%） 8.84%

臨床試驗是推動醫學研究和創新的基石，臨床試驗設備和輔助解決方案的效率和穩健性直接影響新治療方法發現的速度和成功。在過去的十年中，先進技術與傳統方法的結合徹底改變了臨床試驗的進行方式。日益複雜的法規、對數據準確性的不斷提高的期望以及對臨床開發速度的追求都在幫助塑造當前的市場環境。

在這個快速發展的領域，產業相關人員正在尋求解決方案，不僅要確保遵守不斷變化的法規，還要透過簡化流程和增強資料管理能力來提高業務效率。對準確、可靠和經濟高效的工具的追求開啟了一個以數位轉型和對專業臨床試驗設備日益成長的需求為標誌的創新新時代。主要決策者現在準備考慮一系列互補的解決方案，支援從數據收集和管理到患者參與和供應鏈物流的一切。這全面的概述對市場區隔、區域趨勢和競爭動態進行了深入分析，為產業領導者提供了當前和未來商業機會的清晰圖景。

科技與醫療保健的融合繼續推動根本性的改進，創造了一個需要最新設備與先進數位解決方案整合的環境。相關人員可以深入了解不僅影響市場趨勢而且為這一重要產業領域的策略創新和投資鋪路的關鍵因素。

重塑臨床試驗設備格局的變革

在技​​術創新和不斷變化的市場需求的推動下，臨床試驗設備和輔助解決方案的運作模式發生了重大變革時期並被重新定義。新的數位平台簡化了從電子資料擷取到先進的影像處理和監控系統的每個流程，大大縮短了時間並最大限度地減少了人為錯誤。對數據完整性的重視，加上集中化驗服務和先進的臨床試驗管理系統日益成長的重要性，正在為更靈活、敏捷的臨床研究環境鋪平道路。

此外，從傳統的紙本記錄到整合的雲端基礎的系統的演變不僅提高了業務效率，而且從根本上改變了相關人員參與的動態。增強的連接性和數據分析能力使決策者能夠更積極地管理風險並確保合規性。朝向更自動化、可互通的系統邁進凸顯了產業朝向卓越營運的更廣泛趨勢，其中技術創新是實現準確和快速臨床結果的催化劑。隨著這一趨勢的加速，臨床試驗部門將受益於效率的提高、患者治療效果的改善，並最終更快地將突破性治療方法推向市場。

市場區隔分析的關鍵見解

對市場細分的深入研究揭示了一個強大的框架，使相關人員能夠了解影響臨床試驗設備和輔助解決方案格局的各種因素。分析按組件分為兩類，並對輔助解決方案和設備市場進行全面評估。輔助解決方案包含廣泛的專業服務，包括中央實驗室服務、臨床試驗管理系統、數據管理和分析、電子數據採集系統、互動式回應技術、患者參與解決方案以及供應鏈和物流解決方案。同時，設備部門專注於符合嚴格臨床標準的配藥和包裝設備、診斷影像、測試和監測設備。

除了基於組件的細分之外，市場還根據臨床試驗階段進行細分，從第一階段到第四階段。這種細分確保了針對特定需求量身定做的解決方案，例如早期安全評估、劑量最佳化、功效確定和上市後監測。此外，心臟病學、免疫學、感染疾病、神經病學和腫瘤學等治療領域增加了進一步的特殊性，因為它們允許公司解決與每個領域相關的獨特挑戰。

該分析也擴展到最終用戶的觀點，評估學術研究機構、生技公司、受託研究機構、醫療設備公司和製藥公司的市場採用。這種全面的細分使我們能夠細緻地了解客戶需求和市場動態，為在快速變化的臨床試驗環境中最佳化資源配置和最大化投資收益鋪平了道路。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 全球臨床試驗的興起
      • 個人化醫療和標靶治療的興起
      • 臨床研發投入快速增加
    • 限制因素
      • 營運成本高且預算分配有限
    • 機會
      • 持續投資模組化或可攜式測試設備，用於各種臨床試驗設置
      • 加強與遠端醫療提供者的合作，實現與測試設備的無縫整合
    • 任務
      • 臨床試驗流程數位化引發資料隱私擔憂
  • 市場區隔分析
    • 建構模組：擴大臨床試驗儀器的應用，確保準確性與病人安全
    • 治療領域：擴大臨床試驗設備和輔助解決方案在腫瘤學的應用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章臨床試驗設備和支援解決方案市場（按組件）

  • 互補解決方案
    • 中央化驗服務
    • 臨床試驗管理系統（CTMS）
    • 資料管理和分析服務
    • 電子資料擷取（EDC）系統
    • 互動式回應技術（IRT）
    • 病人參與解決方案
    • 供應鏈和物流解決方案
  • 裝置
    • 藥品分配/包裝設備
    • 影像設備
    • 實驗室設備
    • 監控設備

第7章臨床試驗設備和支援解決方案市場（按階段）

  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第8章臨床試驗設備和支援解決方案市場（按治療領域）

  • 心臟病學
  • 免疫學
  • 感染疾病
  • 神經病學
  • 腫瘤學

第9章臨床試驗設備和支援解決方案市場（按最終用戶）

  • 學術研究所
  • 生技公司
  • 合約研究組織（CRO）
  • 醫療設備公司
  • 製藥公司

第 10 章：美洲臨床試驗設備與輔助解決方案市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第 11 章亞太臨床試驗設備與支援解決方案市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第 12 章歐洲、中東和非洲臨床試驗設備及支援解決方案市場

  • 丹麥
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • Almac Group Limited
  • Ancillare, LP
  • Avantor, Inc.
  • Axelerist
  • B. Braun SE
  • Bio-Rad Laboratories, Inc.
  • Charles River Laboratories International, Inc.
  • Dassault Systemes SE
  • Emsere BV
  • Eppendorf SE
  • Eurofins Scientific SE
  • Global Vision Technologies, Inc.
  • Hitachi, Ltd.
  • IQVIA Holdings Inc.
  • Lonza Group Ltd.
  • MedNet Solutions, Inc.
  • Myonex, Inc.
  • Navitas Inc.
  • Oracle Corporation
  • Parexel International Corporation
  • Quanticate International Limited
  • Quipment SAS
  • Royal Philips
  • Thermo Fisher Scientific, Inc.
  • United Parcel Service, Inc.
  • Veeva Systems Inc.
  • Yokogawa Electric Corporation
  • Zifo Technologies Private Limited
Product Code: MRR-8C74ADFC1246

The Clinical Trial Equipment & Ancillary Solutions Market was valued at USD 4.58 billion in 2024 and is projected to grow to USD 5.00 billion in 2025, with a CAGR of 8.84%, reaching USD 7.62 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 4.58 billion
Estimated Year [2025] USD 5.00 billion
Forecast Year [2030] USD 7.62 billion
CAGR (%) 8.84%

Clinical trials have become a cornerstone in advancing medical research and innovation, where the efficiency and robustness of clinical trial equipment and ancillary solutions directly influence the pace and success of new therapeutic discoveries. Over the past decade, the integration of advanced technologies with traditional methods has transformed the way clinical trials are conducted. Increasing regulatory complexities, heightened expectations for data accuracy, and the pursuit of speed in clinical development have all played a role in shaping the current market environment.

In this rapidly evolving space, industry stakeholders are seeking solutions that not only ensure compliance with evolving regulations but also improve operational efficiencies through streamlined processes and enhanced data management capabilities. The quest for precise, reliable, and cost-effective tools has ushered in a new era of innovation characterized by digital transformation and an ever-growing demand for specialized clinical trial equipment. Key decision-makers are now poised to explore a range of ancillary solutions that support everything from data capture and management to patient engagement and supply chain logistics. This comprehensive overview sets the stage for a detailed analysis of market segmentation, regional trends, and competitive dynamics, offering industry leaders a clear window into current and future opportunities.

The convergence of technology and healthcare continues to drive radical improvements, fostering an environment where the integration of modern equipment and advanced digital solutions is critical. Stakeholders can expect a deep dive into the key factors that not only influence market trends but also open avenues for strategic innovation and investment in this crucial industry segment.

Transformative Shifts Reshaping the Clinical Trial Equipment Landscape

Significant transformative shifts have redefined the operational paradigms within clinical trial equipment and ancillary solutions, driven largely by innovations in technology and evolving market demands. Emerging digital platforms have streamlined processes across the board, from electronic data capture to advanced imaging and monitoring systems, drastically reducing timelines and minimizing human error. The emphasis on data integrity, coupled with the rising importance of centralized lab services and sophisticated clinical trial management systems, is paving the way for a more agile and responsive clinical research environment.

Moreover, the evolution from traditional paper-based records to integrated, cloud-based systems has not only increased operational efficiency but has also radically altered the dynamics of stakeholder engagement. Enhanced connectivity and data analytics capabilities have empowered decision-makers to take a more proactive role in managing risks and ensuring compliance. The industry's shift towards more automated and interoperable systems underscores a broader trend towards operational excellence, where technological innovation is the catalyst for precise and rapid clinical outcomes. As these trends accelerate, the clinical trial sector is positioned to benefit from increased efficiencies, improved patient outcomes, and ultimately a faster path to market for groundbreaking therapies.

Key Insights from Market Segmentation Analysis

A deep dive into market segmentation reveals a robust framework that enables stakeholders to understand the diverse elements shaping the clinical trial equipment and ancillary solutions landscape. The analysis is bifurcated by components; the market is thoroughly evaluated across ancillary solutions and equipment. Ancillary solutions incorporate a wide range of specialized services such as central lab services, clinical trial management systems, data management and analytics, electronic data capture systems, interactive response technology, patient engagement solutions, and supply chain and logistics solutions. In contrast, equipment studies focus on drug dispensing and packaging devices, imaging equipment, laboratory instruments, and monitoring devices designed to meet stringent clinical standards.

In addition to the component-based segmentation, the market is segmented by the phase of clinical trials, covering Phase I through Phase IV. This granularity ensures that solutions are tailored to the specific needs of early safety assessments, dosage optimization, efficacy determination, and post-market surveillance. Furthermore, therapeutic areas including cardiology, immunology, infectious diseases, neurology, and oncology add another layer of specificity, permitting companies to address the unique challenges associated with each field.

The analysis also extends to the end-user perspective, evaluating the market's adoption across academic and research institutions, biotechnology firms, contract research organizations, medical device companies, and pharmaceutical companies. This comprehensive segmentation allows for a nuanced understanding of customer needs and market dynamics, paving the way for targeted strategic initiatives that optimize resource allocation and maximize return on investment in a rapidly shifting clinical trials environment.

Based on Component, market is studied across Ancillary Solutions and Equipments. The Ancillary Solutions is further studied across Central Lab Services, Clinical Trial Management Systems (CTMS), Data Management & Analytics Services, Electronic Data Capture (EDC) Systems, Interactive Response Technology (IRT), Patient Engagement Solutions, and Supply Chain & Logistics Solutions. The Equipments is further studied across Drug Dispensing/Packaging Devices, Imaging Equipment, Laboratory Instruments, and Monitoring Device.

Based on Phase, market is studied across Phase I, Phase II, Phase III, and Phase IV.

Based on Therapeutic Area, market is studied across Cardiology, Immunology, Infectious Diseases, Neurology, and Oncology.

Based on End-User, market is studied across Academic/Research Institutions, Biotechnology Firms, Contract Research Organizations (CROs), Medical Device Companies, and Pharmaceutical Companies.

Regional Trends and Insights in Clinical Innovation

The regional analysis of the clinical trial equipment and ancillary solutions market provides a global perspective on the forces shaping industry innovations. In the Americas, robust investments and a mature infrastructure continue to drive advancements, with strong emphasis on regulatory compliance and the adoption of cutting-edge technology solutions. This region effectively balances traditional research methodologies with modern digital technologies, creating an ecosystem that is both resilient and dynamic.

The landscape in Europe, the Middle East, and Africa is characterized by a blend of regulatory diversity and a growing appetite for innovation. The varied regulatory environments combined with significant investments have spurred the adoption of advanced ancillary solutions and equipment designed to meet localized compliance needs. This area benefits from established research institutions and a strong collaborative network that is increasingly turning to digital transformation as a means to address complex challenges.

Meanwhile, the Asia-Pacific region is emerging as a hotbed of innovation, fueled by rapid urbanization, accelerating healthcare reforms, and a rising focus on research and development. Market players in this region are aggressively investing in state-of-the-art laboratories, data-driven insights, and novel ancillary solutions that cater to the needs of a diverse patient population. Together, these regions form a mosaic of growth opportunities, each contributing uniquely to the global evolution of clinical trial technologies and practices.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Finland, France, Germany, Israel, Italy, Netherlands, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, United Arab Emirates, and United Kingdom.

Competitive Dynamics and Company-Level Insights

An in-depth analysis of key companies operating in the clinical trial equipment and ancillary solutions market provides a comprehensive understanding of competitive dynamics and investment potential. The market features a diverse array of prominent players including Almac Group Limited, Ancillare, LP, Avantor, Inc., Axelerist, B. Braun SE, and Bio-Rad Laboratories, Inc. Leading the pack are companies like Charles River Laboratories International, Inc. and Dassault Systemes SE, whose innovative approaches and robust technology platforms set industry benchmarks.

Other influential firms such as Emsere B.V., Eppendorf SE, and Eurofins Scientific SE are further driving the evolution of ancillary services, catering to specialized needs in clinical trial management and data analytics. In parallel, Global Vision Technologies, Inc., Hitachi, Ltd., and IQVIA Holdings Inc. continue to spearhead technological advancements, ensuring that clinical trials are conducted with precision and reliability. Companies like Lonza Group Ltd. and MedNet Solutions, Inc. are instrumental in the development of specialized equipment, aligning their product portfolios with the evolving demands of clinical research.

Industry stalwarts such as Myonex, Inc., Navitas Inc., and Oracle Corporation have harnessed the power of digital transformation to deliver solutions that enhance operational efficiency and data accuracy. Additionally, Parexel International Corporation, Quanticate International Limited, Quipment SAS, Royal Philips, and Thermo Fisher Scientific, Inc. play a crucial role in shaping market trends and setting higher standards for both ancillary solutions and clinical trial equipment. The market is further enriched by the contributions of United Parcel Service, Inc., Veeva Systems Inc., Yokogawa Electric Corporation, and Zifo Technologies Private Limited, all of which are instrumental in redefining how clinical research is conducted on a global scale.

The report delves into recent significant developments in the Clinical Trial Equipment & Ancillary Solutions Market, highlighting leading vendors and their innovative profiles. These include Almac Group Limited, Ancillare, LP, Avantor, Inc., Axelerist, B. Braun SE, Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Dassault Systemes SE, Emsere B.V., Eppendorf SE, Eurofins Scientific SE, Global Vision Technologies, Inc., Hitachi, Ltd., IQVIA Holdings Inc., Lonza Group Ltd., MedNet Solutions, Inc., Myonex, Inc., Navitas Inc., Oracle Corporation, Parexel International Corporation, Quanticate International Limited, Quipment SAS, Royal Philips, Thermo Fisher Scientific, Inc., United Parcel Service, Inc., Veeva Systems Inc., Yokogawa Electric Corporation, and Zifo Technologies Private Limited. Actionable Recommendations for Driving Strategic Growth

Industry leaders are positioned to capitalize on emerging trends and set the stage for long-term growth by embracing integrated strategies that enhance both operational efficiency and technological adoption. It is essential to leverage data analytics and cloud-based solutions to streamline clinical trial management, ensuring that every phase from design to post-market surveillance is executed with precision and speed.

Stakeholders should focus on strategic investments in advanced equipment and ancillary solutions that are adaptable to evolving regulatory frameworks and patient-centric approaches. Strengthening collaborations between research institutions, technology providers, and regulatory bodies can further foster an environment of innovation, ensuring that new entrants and established players alike have access to best practices and the latest market insights. Embracing a forward-looking perspective will enable industry leaders to meet the increasing demands of clinical trials while reducing risks and accelerating time-to-market for groundbreaking therapies.

Concluding Perspectives on Market Transformation and Future Opportunities

In conclusion, the clinical trial equipment and ancillary solutions market is undergoing a period of profound transformation. Anchored by innovative technological advancements, rigorous regulatory standards, and a clear demand for operational excellence, the industry is poised to deliver significant improvements in clinical outcomes and patient engagement. The comprehensive segmentation framework, ranging from component and phase to therapeutic area and end-user, highlights the diverse challenges and opportunities that industry stakeholders must navigate.

The evolving regional dynamics and the robust competition among leading companies underscore the imperative for strategic agility and digital integration. As the market continues to advance, organizations that proactively adopt new technologies and refine their operational frameworks will not only stay ahead of the competition but also contribute to the acceleration of clinical innovation. The insights provided in this analysis serve as a critical roadmap for decision-makers, ensuring that they remain well-informed and strategically positioned to harness the full potential of market opportunities.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising global volume of clinical trials
      • 5.1.1.2. Expansion of personalized medicine and targeted therapies
      • 5.1.1.3. Surge in investments in clinical research and development
    • 5.1.2. Restraints
      • 5.1.2.1. High operational costs and limited budget allocations
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing investments in modular or portable trial equipment for diverse clinical trial setups
      • 5.1.3.2. Increasing collaboration with telemedicine providers for seamless integration with trial equipment
    • 5.1.4. Challenges
      • 5.1.4.1. Data privacy concerns associated with digitization of clinical trial processes
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Increasing adoption of clinical trial equipment for accuracy and patient safety
    • 5.2.2. Therapeutic Area: Expanding usage of clinical trial equipment and ancillary solutions in oncology
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clinical Trial Equipment & Ancillary Solutions Market, by Component

  • 6.1. Introduction
  • 6.2. Ancillary Solutions
    • 6.2.1. Central Lab Services
    • 6.2.2. Clinical Trial Management Systems (CTMS)
    • 6.2.3. Data Management & Analytics Services
    • 6.2.4. Electronic Data Capture (EDC) Systems
    • 6.2.5. Interactive Response Technology (IRT)
    • 6.2.6. Patient Engagement Solutions
    • 6.2.7. Supply Chain & Logistics Solutions
  • 6.3. Equipments
    • 6.3.1. Drug Dispensing/Packaging Devices
    • 6.3.2. Imaging Equipment
    • 6.3.3. Laboratory Instruments
    • 6.3.4. Monitoring Device

7. Clinical Trial Equipment & Ancillary Solutions Market, by Phase

  • 7.1. Introduction
  • 7.2. Phase I
  • 7.3. Phase II
  • 7.4. Phase III
  • 7.5. Phase IV

8. Clinical Trial Equipment & Ancillary Solutions Market, by Therapeutic Area

  • 8.1. Introduction
  • 8.2. Cardiology
  • 8.3. Immunology
  • 8.4. Infectious Diseases
  • 8.5. Neurology
  • 8.6. Oncology

9. Clinical Trial Equipment & Ancillary Solutions Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic/Research Institutions
  • 9.3. Biotechnology Firms
  • 9.4. Contract Research Organizations (CROs)
  • 9.5. Medical Device Companies
  • 9.6. Pharmaceutical Companies

10. Americas Clinical Trial Equipment & Ancillary Solutions Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Finland
  • 12.4. France
  • 12.5. Germany
  • 12.6. Israel
  • 12.7. Italy
  • 12.8. Netherlands
  • 12.9. Norway
  • 12.10. Poland
  • 12.11. Qatar
  • 12.12. Russia
  • 12.13. Saudi Arabia
  • 12.14. South Africa
  • 12.15. Spain
  • 12.16. Sweden
  • 12.17. Switzerland
  • 12.18. United Arab Emirates
  • 12.19. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Ancillare enhances cold chain management services for clinical trial supplies
    • 13.3.2. PRONAV Clinical strategically expanded its U.S. footprint by joining FITCI's entrepreneurial ecosystem
    • 13.3.3. Myonex strategically acquired CREAPHARM's pharmaceutical services business,
    • 13.3.4. RQM+ Acquires Libra Medical
    • 13.3.5. Lambda Therapeutics partners with Medidata to automate and streamline data management processes for greater clinical trial efficiency
    • 13.3.6. Mednet Launches DICOM Imaging Capabilities Within the iMednet eClinical Platform
    • 13.3.7. Launch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development
    • 13.3.8. Clinical ink Announces Strategic Partnership with Mural Health for New Patient Payment and Logistics Capabilities
    • 13.3.9. Cloudbyz Unveils Groundbreaking Electronic Data Capture Solution to Streamline Clinical Research and Accelerate Launch of New Therapies
    • 13.3.10. Clario Launches Cloud-Based Image Viewer for Clinical Trials
    • 13.3.11. ClinChoice continues expansion with CRO acquisition
    • 13.3.12. Suvoda launches purpose-built software platform
    • 13.3.13. Huma acquires Alcedis to expand clinical trial platform
    • 13.3.14. CardieX Subsidiary ATCOR Partners with Invaryant to Enable Clinical Trials with Advanced New AI Medical Technology
    • 13.3.15. RQM+ Launches Clinical Trial Services
    • 13.3.16. Edison Partners leads USD 21 million funding round for clinical trial intelligence disruptor Lokavant
    • 13.3.17. Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China
    • 13.3.18. Philips launches 12-lead ECG solution for decentralized clinical trials
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Almac Group Limited
  • 2. Ancillare, LP
  • 3. Avantor, Inc.
  • 4. Axelerist
  • 5. B. Braun SE
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Charles River Laboratories International, Inc.
  • 8. Dassault Systemes SE
  • 9. Emsere B.V.
  • 10. Eppendorf SE
  • 11. Eurofins Scientific SE
  • 12. Global Vision Technologies, Inc.
  • 13. Hitachi, Ltd.
  • 14. IQVIA Holdings Inc.
  • 15. Lonza Group Ltd.
  • 16. MedNet Solutions, Inc.
  • 17. Myonex, Inc.
  • 18. Navitas Inc.
  • 19. Oracle Corporation
  • 20. Parexel International Corporation
  • 21. Quanticate International Limited
  • 22. Quipment SAS
  • 23. Royal Philips
  • 24. Thermo Fisher Scientific, Inc.
  • 25. United Parcel Service, Inc.
  • 26. Veeva Systems Inc.
  • 27. Yokogawa Electric Corporation
  • 28. Zifo Technologies Private Limited

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET MULTI-CURRENCY
  • FIGURE 2. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET MULTI-LANGUAGE
  • FIGURE 3. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET RESEARCH PROCESS
  • FIGURE 4. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET DYNAMICS
  • TABLE 7. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CENTRAL LAB SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DATA MANAGEMENT & ANALYTICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ELECTRONIC DATA CAPTURE (EDC) SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INTERACTIVE RESPONSE TECHNOLOGY (IRT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PATIENT ENGAGEMENT SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SUPPLY CHAIN & LOGISTICS SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DRUG DISPENSING/PACKAGING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMAGING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY LABORATORY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MONITORING DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ACADEMIC/RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 124. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 130. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 131. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 132. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 138. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 142. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 143. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 144. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 148. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 149. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 150. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 154. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 155. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 156. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 167. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 168. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 169. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. UNITED ARAB EMIRATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 261. UNITED ARAB EMIRATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 262. UNITED ARAB EMIRATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 263. UNITED ARAB EMIRATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 264. UNITED ARAB EMIRATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 265. UNITED ARAB EMIRATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED KINGDOM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED KINGDOM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED KINGDOM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED KINGDOM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED KINGDOM CLINICAL TRIAL EQUIPM